|
The following stocks are the leading risers and fallers on AIM on Tuesday. ---------- AIM - WINNERS ---------- Oxford BioDynamics PLC, more than doubled at 0.58 pence from 0.26p, 12-month range 0.25p-8.40p. The clinical diagnostics company notes that Pfizer Inc has published on the successful use of EpiSwitch biomarkers in evaluating tumour status and treatment outcomes in the Javelin Bladder 100 trial. Oxford BioDynamics says the data demonstrates that EpiSwitch biomarkers in blood samples strongly correlate with the immune profiles of tumours. ‘The results from the published Pfizer study are a powerful endorsement for our blood-based biomarker EpiSwitch technology,’ says Chief Scientific Officer Alexandre Akoulitchev. ---------- Eagle Eye Solutions Group PLC, up 8.1% at 227.00p, 12-month range 500.00p-190.00p. The digital marketing firm says revenue in the twelve months to June was up 1.0% to £48.2 million from £47.7 million a year ago. Adjusted earnings before interest, tax, depreciation and amortisation are 8.0% higher at £12.2 million from £11.3 million. The company says trading in the second half has delivered adjusted Ebitda ahead of current market expectations for the year, which were for adjusted Ebitda of £11.3 million. Eagle Eye says it has a ‘solid foundation’ for the new financial year from a strong sales pipeline and annual recurring revenue. ‘We are pleased to report a solid set of results for FY25, demonstrating the strong fundamentals of the business and our continued cost discipline,’ Chief Executive Officer Tim Mason says. Eagle Eye launches a £1.0 million share buyback programme to run until the end of February 2026. ---------- AIM - LOSERS ---------- Sosandar PLC, down 20% at 6.38p, 12-month range 11.43p-4.95p. The online women’s fashion brand warns of a below consensus financial performance. The company says it is taking the ‘prudent view’ of changing its guidance in light of a cyberattack at Marks & Spencer Group PLC. Sosandar products are available on the M&S online shop. It now expects revenue for the year to the end of March 2026 of £43.6 million and an adjusted pretax profit of £400,000. It believes market expectations stand at £46.2 million for revenue and £1.5 million for adjusted pretax profit. The company reports revenue of £37.1 million for the year to the end of March 2025, down 20% from £46.3 million a year ago. Pretax loss narrows to £67,000 from £332,000. ‘Taking the decision to reduce price promotions has resulted in an expected reduction in revenue but significantly improved margins and cash generation which, in turn, has allowed the group to maintain a robust balance sheet and self-fund its growth plan,’ say Co-CEOs Ali Hall and Julie Lavington. ---------- Cirata PLC, down 17% at 23.95p, 12-month range 60.30p-16.00p. The software solutions provider says total bookings in the second quarter to June are down 53% to $800,000 from $1.7 million a year ago. The company says cash burn has reduced to $2.2 million from $4.2 million. Cirata leaves its outlook unchanged as it says it expects bookings to be back end weighted. The firm says it has agreed to sell its DevOps assets to BlueOptima for up to $3.5 million. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
